NCT05320380 2023-09-01
A Study of the Drug IMGN632 in Children With Leukemia That Has Come Back After Treatment or is Difficult to Treat
Children's Oncology Group
Phase 1/2 Withdrawn
Clinical Trials
1 trialsPhase 1/2 × Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × hydrocortisone hemisuccinate × Clear all